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Vascularization is crucial process for the success of tissue en-
gineered constructs. Without a proper vascular network, implants,
both in vivo and in vitro, suffer from hypoxia, lack of nutrients and
accumulation of waste products that ultimately result in cell death.
This problem can be circumvented by promoting enhanced blood
vessel ingrowth into the implant. To this end, we created an in vitro
system using Endothelial Progenitor Cells (EPCs) and a PLA/
calcium phosphate glass composite (PLA/G5) developed in our
group for bone regeneration (Charles-Harris et al, 2005). These
scaffolds show a high porosity (95%) and a pore size larger than
500 um with very open interconnected porosity. We expected G5
particles to introduce bioactivity in the composite, improving bone
and vascular tissue regeneration. EPCs are stem cells that can be
isolated from bone marrow. They show expression of several en-
dothelial and stem cell markers (CD31, CD34, VEGFR-2, vWF)
and have strong vasculogenic properties. Our results showed that
proliferation-measured by the WST-1 method was increased
compared to controls. Acridine Orange staining for live/dead cells
showed good viability, with no observable apoptotic or necrotic
cells. After 3 days, cells assembled into long tube-like structures
with sprouts delving deeper into the material. We decided to test its
possible angiogenic properties by comparing cells seeded in PLA/
G5 and in angiogenic conditions. Tubule density quantiﬁcation
results demonstrated a strong induction of angiogenesis on PLA/
G5 discs. Our next steps are to establish co-cultures of EPCs-MSCs
for bone and vessel regeneration and measuring differentiation by
qRT-PCR.
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In situ cartilage tissue engineering represents an alternative ap-
proach to treat degenerated articular cartilage in osteoarthritis. The
concept aims to recruit mesenchymal stem cells from bone marrow
by means of chemotactic agents to the defect padded with bio-
materials. Present there cells are induced to proliferate and dif-
ferentiate to restore articular surface. It was the aim of this study to
investigate the differentiation potential as well as the chemokine
guided migration potential of human mesenchymal stem cells de-
rived from patients with osteoarthritis.
Cells were isolated from femoral heads derived from patients
undergoing total hip athroplasty, expanded, checked for standard
surface marker proﬁle and differentiated towards osteogenic,
chondrogenic and adipogenic lineage using standard differentia-
tion assays. A 96-well plate chemotaxis assay was used to inves-
tigate the migratory response to a set of chemokines. Finally gene
expression of the isolated cells during chondrogenic differentiation
in ﬁbrin-PGLA biomaterial constructs was analyzed using micro-
arrays.
FACS analysis revealed a typical mesenchymal stem cell sur-
face marker proﬁle (CD44þ, CD73þ, CD90þ, CD105þ,
CD166þ, CD14-, CD34-, CD45-). In multilineage differentiation
assays histochemistry conﬁrmed chondrogenic, adipogenic and
osteogenic potential of the isolated cell populations by formation
of collagen type II, lipid vacuoles and calcium deposits, respec-
tively. Chemotaxis experiments could demonstrate migratory re-
sponse to CCL25. Cells maintained in 3D culture showed proper
viability over six weeks, expression proﬁling supported chondro-
genic potential as typical markers were clearly up-regulated
(COL2A1, COMP, ACAN, etc.).
To conclude, human mesenchymal stem cells from patients with
OA showed feasibility for in situ tissue engineering.
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Chitosan membranes were prepared by solvent casting and cross-
linked with glutaraldehyde at several ratios under homogenous
conditions. The crosslinking degree varying from 0 to 20% is de-
ﬁned as the ratio between the total aldehyde groups and the amine
groups of chitosan. Permeability experiments were conducted us-
ing a side-by-side diffusion cell to determine the ﬂux of small
molecules of similar size, but holding different chemical moieties,
either ionised (benzoic acid, salicylic acid and phthalic acid) or
neutral (2-phenylethanol) at physiological pH. The permeability of
the different model molecules revealed to be dependent on the
afﬁnity of those structurally similar molecules to chitosan, i.e.,
related to the partition coefﬁcient determined in an independent
experiment. The permeability of the salicylate anion was enhanced
by the presence of metal cations commonly present in biological
ﬂuids, such as calcium and magnesium, but remained unchanged
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for the neutral 2-phenylethanol. This effect was explained by the
chelation of metal cations on the amine groups of chitosan, which
increased the partition coefﬁcient. The crosslinking degree was
also correlated with the permeability and partition coefﬁcient. The
change in the permeation properties of chitosan to anionic solutes
in the presence of these metallic cations is an important result
and should be taken into consideration in the in vitro predictions of
the drug release from chitosan based controlled drug release sys-
tems.
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Introduction: Treatment of diabetic foot ulcers includes necrotic
tissue debridement, infection control, mechanic discharge and
whenever possible, revascularization of the lesion. Nevertheless
there are not many therapies that improve tissue regeneration and
wound healing. The use of tissue-enginneered constructs could
help to regenerate these lesions.
Aim of Study: The aim of this study is to assess the effects of the
transplant of an artiﬁcial, tissue-engineered dermis in the healing
of surgical injuries of diabetic foot.
M&M: Artiﬁcial Dermis: Fibroblasts were obtained from skin
biopsies of tissue donors from our bank. The artiﬁcial dermis was
made by mixing cultured ﬁbroblasts and donors plasma. This
mixture was clotted by adding CaCl2.
Patients: 15 diabetic patients (bearing open injuries that did not
ameliorate for the past 4 weeks) were included in the study. One
dermal graft was transplanted on the wound bed once a week until
wound healing or, if adverse events appeared, suppression of the
treatment.
Results: 15 patients were treated. Wound healing was achieved
in 80% cases. The mean period of wound closure was 7 weeks. The
mean hospitalisation period was 2.5 weeks. Neither reject signs nor
secondary complications were observed.
Conclusion: The treatment of post-surgical wounds in the dia-
betic foot using an artiﬁcial dermis is a reliable and secure pro-
cedure.
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Umbilical cords have been identiﬁed as a potential niche for har-
vesting numerous multipotential progenitor cells. Contemporary
isolation protocols generate heterogeneous cell populations con-
stituting numerous stem and progenitor cell populations each
exhibiting shifting degrees of multipotentiality. Homogeneously
isolating each subpopulation and gauging therapeutic potential may
highlight umbilical cord as a potential cell source for clinical ap-
plications. Furthermore, utilisation of autologous cells overcomes
immune compromises associated with tissue engineering.
Wharton’s jelly was circumspectly dissected from washed cords
and plated into 6 well plates with basal media. Undifferentiated
conﬂuent cells were removed and analysed by ﬂow cytometry.
Cells were cultured in media known to cause lineage differentia-
tion along adipogenic, chondrogenic, osteogenic and neurogenic
pathways. Phenotyping by immunostaining, histological staining
and western blotting for proteins associated with the desired line-
age was carried out at 7, 14, 21 and 28 days.
Undifferentiated cells expressed the MSCmarkers CD29, CD90,
CD105, CD146 and CD166 as observed by ﬂow cytometry. Ex-
pression of the ES markers CD9, CD30, CD56 and CD135 suggest
the presence of cells with increased plasticity. Further analysis of
the undifferentiated population demonstrated expression of STRO-
1 and the stem cell proliferation marker Nucleostemin within
subsets of the population. Cells introduced into adipogenic,
chondrogenic, osteogenic and neurogenic differentiation medias
exhibited differentiation towards the desired lineage, as conﬁrmed
by morphological examination, immunostaining and western
blotting.
It is therefore concluded that umbilical cord tissue is a good
source of progenitor cells with multipotentiality.
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There are some intrahepatic liver stem cells, such as oval cells in
relation to liver regeneration. However, recently it has been re-
ported that extrahepatic liver stem cells exist in bone marrow and
contribute to liver regeneration. Many researchers have investi-
gated which cell can differentiate into hepatocyte and contribute to
liver. Until now their potential is yet controversial. Besides HSC,
there are many origins of MSC, bone marrow (BM), adipose tissue
(AT), cord blood, and cord Wharton’s jelly (UC).
Moreover, it is reported that BM-, AT-, UC-MSCs can differ-
entiate into hepatocyte in vitro or after in vivo transplantation. We
have focused on UC-MSC as a stem cell source, because UC-MSC
can be easily isolated and cultured from generally discarded cord
tissue without any ethical problem.
So we conﬁrmed whether the isolated cell from cord by our
protocol is one of MSCs or not using FACS and differentiation
analysis. After that, we checked which condition can improve the
differentiation of UC-MSC into hepatocyte. In addition to in vitro
experiment, we transplanted UC-MSCs into rats with liver fail-
ure induced by bile duct ligation, carbon tetrachloride intoxiﬁcation.
As results, UC-MSCs could differentiate into hepatocytes ex-
pressing not only hepatocyte lineage markers (albumin, CK8,
CK18) but also liver-speciﬁc functions (albumin and urea syn-
theses, cytochrome P450 activities) in vitro. In conclusion, UC-
MSCs will be a good stem cell source not only for hepatic cell
therapy but also for bioartiﬁcial liver system in the ﬁeld of re-
generative medicine.
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